ATE387459T1 - Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie - Google Patents
Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämieInfo
- Publication number
- ATE387459T1 ATE387459T1 AT01926716T AT01926716T ATE387459T1 AT E387459 T1 ATE387459 T1 AT E387459T1 AT 01926716 T AT01926716 T AT 01926716T AT 01926716 T AT01926716 T AT 01926716T AT E387459 T1 ATE387459 T1 AT E387459T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- compounds
- lowering cholesterol
- cholesterol levels
- inducing hypertriglyceridemia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54438600A | 2000-04-06 | 2000-04-06 | |
| US67908800A | 2000-10-04 | 2000-10-04 | |
| US09/827,854 US20020123093A1 (en) | 2000-04-06 | 2001-04-05 | Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE387459T1 true ATE387459T1 (de) | 2008-03-15 |
Family
ID=27415432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01926716T ATE387459T1 (de) | 2000-04-06 | 2001-04-06 | Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060142200A1 (de) |
| EP (1) | EP1274717B1 (de) |
| JP (1) | JP2003530835A (de) |
| AT (1) | ATE387459T1 (de) |
| AU (2) | AU5323301A (de) |
| CA (1) | CA2405870A1 (de) |
| MX (1) | MXPA02009804A (de) |
| NO (1) | NO20024769L (de) |
| WO (1) | WO2001077136A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE533783T1 (de) * | 2006-12-13 | 2011-12-15 | Univ California | Potente und selektive mittlersubstanzen von cholesterolefflux |
| EP3842514A1 (de) * | 2014-09-12 | 2021-06-30 | Whitehead Institute for Biomedical Research | Zellen zur expression von apolipoprotein e und verwendungen davon |
| JP2020537542A (ja) | 2017-10-03 | 2020-12-24 | プリベイル セラピューティクス, インコーポレーテッドPrevail Therapeutics, Inc. | ライソゾーム病の遺伝子治療 |
| CN112481269A (zh) | 2017-10-03 | 2021-03-12 | 普利维尔治疗公司 | 用于溶酶体障碍的基因疗法 |
| WO2020112802A1 (en) * | 2018-11-28 | 2020-06-04 | Prevail Therapeutics, Inc. | Gene therapies for neurodegenerative disease |
| WO2022115535A1 (en) * | 2020-11-25 | 2022-06-02 | Prevail Therapeutics, Inc. | Gene therapies for neurodegenerative disease |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08501686A (ja) * | 1992-09-25 | 1996-02-27 | ローン−プーラン・ロレ・ソシエテ・アノニム | 中枢神経系、特に脳における細胞への外来遺伝子の転移のためのアデノウィルスベクター |
| AU7019494A (en) * | 1993-05-20 | 1994-12-20 | Baylor College Of Medicine | Genetic therapy for cardiovascular disease |
| US5811243A (en) * | 1993-08-31 | 1998-09-22 | Duke University | Methods and compositions for binding tau and MAP2c proteins |
| AU7142796A (en) * | 1995-10-02 | 1997-04-28 | Erasmus University Rotterdam | Diagnosis method and reagents |
-
2001
- 2001-04-06 WO PCT/US2001/011358 patent/WO2001077136A1/en active IP Right Grant
- 2001-04-06 JP JP2001575606A patent/JP2003530835A/ja not_active Withdrawn
- 2001-04-06 MX MXPA02009804A patent/MXPA02009804A/es active IP Right Grant
- 2001-04-06 EP EP01926716A patent/EP1274717B1/de not_active Expired - Lifetime
- 2001-04-06 AU AU5323301A patent/AU5323301A/xx active Pending
- 2001-04-06 AU AU2001253233A patent/AU2001253233B2/en not_active Ceased
- 2001-04-06 AT AT01926716T patent/ATE387459T1/de not_active IP Right Cessation
- 2001-04-06 CA CA002405870A patent/CA2405870A1/en not_active Abandoned
-
2002
- 2002-10-03 NO NO20024769A patent/NO20024769L/no not_active Application Discontinuation
-
2006
- 2006-02-24 US US11/361,788 patent/US20060142200A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO20024769D0 (no) | 2002-10-03 |
| EP1274717A4 (de) | 2004-07-14 |
| AU5323301A (en) | 2001-10-23 |
| CA2405870A1 (en) | 2001-10-18 |
| AU2001253233B2 (en) | 2006-12-07 |
| EP1274717A1 (de) | 2003-01-15 |
| EP1274717B1 (de) | 2008-02-27 |
| US20060142200A1 (en) | 2006-06-29 |
| NO20024769L (no) | 2002-11-26 |
| WO2001077136A1 (en) | 2001-10-18 |
| MXPA02009804A (es) | 2003-07-14 |
| JP2003530835A (ja) | 2003-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200501772A1 (ru) | Способы измерения экспрессии генов из фиксированного и залитого в парафин образца ткани | |
| DK1261360T3 (da) | Casein-afledte peptider og anvendelser deraf i behandling | |
| ATE230417T1 (de) | Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien | |
| ATE364696T1 (de) | Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts | |
| DE602004020999D1 (de) | Materialien und verfahren zum einfangen von krankheitserregern und zur abtrennung von aurintricarbonsäure aus einer probe | |
| ATE275411T1 (de) | Verwendung von phyllanthus zur behandlung von chronisch entzündlichen und fibrotischen prozessen | |
| DE60101354T2 (de) | Diorganopolysiloxan/Acrylat-Copolymer enthaltende Emulsionen zur Behandlung von Flächengebilden | |
| ATE387459T1 (de) | Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie | |
| ATE345354T1 (de) | Methode zur identifizierung von helicobacter antigenen | |
| ATE313561T1 (de) | Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen | |
| DE60334499D1 (de) | Verfahren zur erhöhung der ausbreitung von b-zellen | |
| NO20060420L (no) | 2-aminobenzoylderivater | |
| ATE437223T1 (de) | Attenuiertes bovines respiratorisches syncytialvirus | |
| ATE476987T1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen | |
| DE50110552D1 (de) | Verfahren zur behandlung von instabiler angina pectoris | |
| DE602004001047D1 (de) | Phospholipidester von Clofarabin | |
| ATE410517T1 (de) | Mittel und verfahren zur expression von homologen und heterologen proteinen in rhodococcus | |
| DE60132986D1 (de) | Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie | |
| DK1339737T3 (da) | Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirus | |
| ATE407925T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
| DE602005016697D1 (de) | Molekulardiagnoseverfahren und behandlung von demenz mit lewy-körperchen | |
| DE60319719D1 (de) | Verfahren zur voraussage der erhöhung von cholesterin während einer immunosuppresiven therapie | |
| BR0013665A (pt) | Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite | |
| DE60005526D1 (de) | Verwendung von 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine zur behandlung von erkrankungen des magen-darm-traktes | |
| ATE402147T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |